Shanghai Pharmaceuticals: Alprazolam Tablets Obtained Pharmaceutical Registration Certificate in the Philippines

Shanghai Pharmaceutical announced that the drug registration certificate for Alprazolam tablets produced by its subsidiary, Shanghai Shang Yao Chinese and Western Pharmaceuticals Co., Ltd., has been issued by the Food and Drug Administration of the Philippines, and the drug has been approved for listing. Alprazolam tablets are an antipsychotic drug mainly used to treat manic episodes in schizophrenia and bipolar disorder, and can also be used as an adjunctive therapy for depression. The company has invested approximately 50,000 RMB for the registration of the drug in the Philippines. The total sales of Alprazolam tablets in the Philippines market in 2024 amounted to 2.39 million US dollars.